The global industry was valued at US$ 527.5 Mn in 2024 and is projected to exceed US$ 771.0 Mn by 2035, growing at a CAGR of ...

AbTree Biologics AG has signed an exclusive co-development and commercialization partnership with Shilpa Biologicals Pvt Ltd. (a fully owned subsidiary of Shilpa Medicare Limited) for its novel ...

Sciensus, a leading European life sciences organisation, focused on accelerating patients’ access to lifesaving medicines, is pleased to announce that Kerry Utton has joined the business leading our ...

MedExecWomen, a non-profit organization focused on empowering executive women in medtech to accelerate the positive impact of medical devices, diagnostics, drug delivery, and digital healthcare around ...

Clean water is essential for daily life and life science applications. Researchers use demineralization to maintain water quality, though traditional methods might not keep up with changing conditions ...

Technology is transforming how people monitor and maintain hygiene in critical environments like healthcare facilities and laboratories. This is where game-changing innovations like IoT come in. What ...

March-2025 / 06:59 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.PRESS RELEASERelease of an ad hoc announcement ...

The global Wearable Pulse Oximeters Market was valued at US$ 309.0 Mn in 2021 and is projected to expand at a CAGR of 7.0% from 2022 to 2031, reaching more than US$ 594.5 Mn by the end of 2031.

The global Dialysis Equipment Market was valued at US$ 16.0 Bn in 2022 and is projected to expand at a CAGR of 5.5% from 2023 to 2031, reaching more than US$ 25.2 Bn by the end of 2031. The increasing ...

Terumo Blood and Cell Technologies, (Terumo BCT), a medical technology company, signed a memorandum of understanding (MOU) with Osong Medical Innovation Foundation (KBIOHealth) toward joint ...

The Smart Medical Implants Market was valued at US$ 5.7 Bn in 2022 and is projected to grow at a CAGR of 18.1% from 2023 to 2031, reaching more than US$ 24.8 Bn by the end of 2031. The increasing ...

Sofinnova Partners (“Sofinnova"), a leading European life sciences venture capital firm based in Paris, London, and Milan, today announced the final close of Sofinnova Biovelocita II. The fund has ...